Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT03524092
Other study ID # 16823
Secondary ID I6T-MC-AMBG2017-
Status Active, not recruiting
Phase Phase 3
First received
Last updated
Start date October 19, 2018
Est. completion date December 20, 2024

Study information

Verified date March 2024
Source Eli Lilly and Company
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to evaluate the efficacy and safety of mirikizumab as maintenance therapy in participants who completed as clinical responders in the prior 12-week induction study LUCENT-1 (NCT03518086).


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 1177
Est. completion date December 20, 2024
Est. primary completion date November 3, 2021
Accepts healthy volunteers No
Gender All
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria: - Have completed Study AMAN (NCT03518086), with at least 1 study drug administration and without early termination of study drug. - Are willing and able to complete the scheduled study assessments, including endoscopy and daily diary entry. - If female, must meet the contraception requirements. Exclusion Criteria: - Participants diagnosed with Crohn's disease or inflammatory bowel disease-unclassified (indeterminate colitis) during the induction study AMAN (NCT03518086). - Participants with a bowel resection or other surgery for the treatment of UC during the previous induction study AMAN (NCT03518086), or are likely to require surgery for the treatment of UC during study AMBG. - Participants with evidence of colonic dysplasia or have been diagnosed with cancer of the gastrointestinal tract during study AMAN (NCT03518086). - Participants diagnosed with clinically important infection including, but not limited to, hepatitis B, hepatitis C, HIV/AIDS, and active tuberculosis (TB) during the induction study AMAN (NCT03518086). - Participants who initiate a new prohibited medication during the induction study AMAN (NCT03518086). - Participants with certain laboratory abnormalities prior to start of AMBG that would require permanent discontinuation from study drug.

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Mirikizumab SC
Administered SC
Mirikizumab IV
Administered IV
Placebo SC
Administered SC

Locations

Country Name City State
Argentina Centro de Investigaciones Metabólicas (CINME) Caba Buenos Aires
Argentina Mautalen Salud e Investigacion-Centro de Osteopatías Médicas Ciudad Autonoma De Buenos Air Buenos Aires
Argentina Hospital Privado Centro Medico de Cordoba SA Cordoba
Argentina CER Instituto Medico Quilmes Buenos Aires
Argentina Fundación de Estudios Clínicos Rosario Santa Fe
Argentina Centro de Investigaciones Médicas Tucuman SAN M. DE Tucuman Tucumán
Argentina C.I.C.E. 9 de Julio San Miguel de Tucumán Tucumán
Australia Royal Adelaide Hospital Adelaide South Australia
Australia Box Hill Hospital Outpatients Box Hill Victoria
Australia Princess Alexandra Hospital Harlow Essex
Australia Melbourne Gastrointestinal Investigation Unit (MGIU) Malvern Victoria
Australia Coastal Digestive Health Maroochydore Queensland
Australia The Alfred Hospital Melbourne Victoria
Australia The Royal Melbourne Hospital Parkville Victoria
Australia Mater University Hospital South Brisbane Queensland
Austria Medizinische Universität Innsbruck Innsbruck
Austria Universitätsklinikum Salzburg Salzburg
Austria Medical University of Vienna Vienna
Belgium AZ Klina Brasschaat
Belgium Universitair Ziekenhuis Gent Gent Oost-Vlaanderen
Belgium Universitaire Ziekenhuizen Leuven - Campus Gasthuisberg Leuven
Belgium Centre Hospitalier de Wallonie Picarde - Site Notre Dame Tournai Wallonne, Région
Canada West Edmonton Diabetes Center Edmonton Alberta
Canada Centre de santé et de services sociaux Champlain-Charles-Le Moyne Greenfield Park Quebec
Canada University of Western Ontario London Ontario
Canada Victoria Hospital London Ontario
Canada Hopital Maisonneure-Rosemount Montreal Quebec
Canada Inflammatory Bowel Disease Centre Montreal General Hospital - MUHC Montreal Quebec
Canada GI Research Institute Vancouver British Columbia
Canada The Gordon and Leslie Diamond Health Care Centre Vancouver British Columbia
Canada PerCuro Clinical Research Victoria British Columbia
China Beijing Friendship Hospital Beijing Beijing
China Changzhou No.2 People's Hospital Changzhou Jiangsu
China West China Hospital, Sichuan University Chengdu Sichuan
China The Affiliated 2nd Hosp. of Third Military Med. Univ. of PLA Chongqing Chongqing
China The First Hospital Affiliated to AMU (Southwest Hospital) Chongqing Chongqing
China The Second Hospital of Dalian Medical University Dalian Lianing
China Fujian Province Hospital Fuzhou Fujian
China The Sixth Affiliated Hospital, Sun Yat-Sen University Guangzhou Guangdong
China Hainan General Hospital Haikou Hainan
China First Affiliated Hosp of College of Med, Zhejiang University Hangzhou Zhejiang
China Sir Run Run Shaw Hospital Hangzhou Zhejiang
China The Second Affiliated Hospital of Zhejiang University School of Med Hangzhou Zhejiang
China Anhui Provincial Hospital Hefei City Anhui
China The First Affiliated Hospital of Anhui Medical University HefeiCity Anhui
China Jilin Central General Hospital Jilin Jilin
China Qilu Hospital of Shandong University Jinan Shandong
China Shandong Provincial Hospital Jinan Shandong
China Xiangya Hospital Central South University Kaifu District Changsha City
China Kunming Medical College Affiliated First Hospital Kunming Yunnan
China The First People's Hospital of Yunnan Province Kunming Yunnan
China Liaocheng People's Hospital Liaocheng Shandong
China The First Affiliated Hospital of Nanchang University Nanchang Jiangxi
China Jiangsu Province Hospital Nanjing Jiangsu
China Jiangsu Province Hospital of Chinese Medicine Nanjing Jiangsu
China Nanjing Medical University - Nanjing Jiangning Hospital Nanjing Jiangsu
China The Affiliated Drum Tower Hospital of Nanjing University Nanjing Jiangsu
China Zhongda Hospital Southeast University Nanjing Jiangsu
China Jiangxi Pingxiang People's Hospital Pingxiang Jiangxi
China The Affiliated Hospital of Qingdao University Qingdao Shandong
China Renji Hospital Affliated to Shanghai Jiaotong University Shanghai Shanghai
China Shanghai Jiaotong University School of Medicine Ruijin Hospital Shanghai Shanghai
China Shengjing Hospital of China Medical University Shenyang Liaoning
China Shengjing Hospital of China Medical University Shenyang City Liaoning
China The University of Hong Kong-Shenzhen Hospital Shenzhen Guangdong
China Taian City Central Hospital Taian Shandong
China No.1 Hospital Affiliated to Xinjiang Medical University Urumchi Urumchi
China The Second Affiliated Hospital YuYing Childens Hospital of Wenzhou Medical university Wenzhou Zhejiang
China Renmin Hospital of Wuhan University Wuhan Hubei
China Tongji Hospital of Tongji University Wuhan
China Union Hospital Tongji Medical College Huazhong University of Science and Technology Wuhan Hubei
China The Second Affiliated Hospital of Zhengzhou University Zhengzhou Shi Henan
China ZhuZhou Central Hospital ZhuZhou Hunan
Czechia Fakultni Nemocnice u sv. Anny v Brne Brno
Czechia Vojenská Nemocnice Brno Brno Brno-mesto
Czechia Hepato-Gastroenterologie HK Hradec Kralove Hradec Králové
Czechia MUDr. Gregar, s.r.o. Olomouc Olomoucký Kraj
Czechia PreventaMed, s.r.o. Olomouc
Czechia A-Shine Pilsen Plzen-mesto
Czechia MEDIENDO Prague Praha 8
Czechia Fakultni nemocnice Kralovske Vinohrady Praha 10 Hl. M. Praha
Czechia ISCARE Clinical Centre Praha 9
Denmark Herlev and Gentofte Hospital Herlev
Denmark Zealand University Hospital Køge Køge
France CHU Amiens Picardie-Site Sud - RDC Service Hépato gastro Amiens Cedex Somme
France CHU Tours - Hôpital Trousseau Chambray les Tours
France Hôpital Beaujon Clichy Paris
France CHU Lille - Hôpital Claude Huriez Lille cedex Nord
France Assistance Publique Hôpitaux de Marseille - Hôpital Nord Marseille Cedex 20
France CHRU de Montpellier-Hopital St Eloi Montpellier Cedex 5
France Hopital L'Archet 2 Nice Cedex
France Hopital Saint-Louis Paris Cedex 10
France Centre Hospitalier de Pau Pau Pyrénées-Atlantiques
France CHU Bordeaux - Hôpital Haut-Lévêque Pessac Cedex
France Hospices Civils de Lyon - Centre Hospitalier Lyon Sud - Pierre Benite cedex Rhone
France Robert Debre Hospital Reims
France CHU de Saint Etienne Hopital Nord Saint Priest en Jarez
France Hopital de Hautepierre - Service d'Hépatogastroentérolgie Strasbourg Cedex Bas Rhin
France CHRU Nancy Brabois - Hôpital d'Enfants Vandoeuvre les Nancy
Germany Charité Campus Virchow-Klinikum Berlin
Germany Krankenhaus Waldfriede Berlin
Germany Städtisches Klinikum Brandenburg Brandenburg
Germany Studiengesellschaft BSF Unternehmergesellschaft Halle (Saale) Sachsen-Anhalt
Germany Universitätsklinikum Halle Halle (Saale) Sachsen-Anhalt
Germany HaFCED - Hamburgisches Forschungsinstitut für chronisch entzündliche Darmerkrankungen Hamburg
Germany Medizinische Hochschule Hanover Hannover Niedersachsen
Germany Gemeinschaftspraxis Dr. Peter Uebel Ludwigshafen am Rhein Rheinland-Pfalz
Germany Internistische Praxisgemeinschaft Weyhe
Hungary DRC Gyogyszervizsgalo Kozpont Kft. Balatonfüred EU
Hungary Óbudai Egészségügyi Centrum Budapest
Hungary Semmelweis Egyetem Budapest
Hungary Debreceni Egyetem Klinikai Kozpont Debrecen
Hungary Endomedix Diagnosztikai Központ - Miskolc Miskolc
Hungary Karolina Korhaz-Rendelointezet Mosonmagyarovar
Hungary Szegedi Tudomanyegyetem Szent-Gyorgyi Albert Klinikai Kozpont I. Belgyogyaszati Klinika Szeged
Hungary CLINFAN Szolgáltató Kft Szekszard
Hungary Jávorszky Ödön Kórház Vác Pest
India Bangalore Medical College and Research Institute Bangalore Karnataka
India M S Ramaiah Medical College and Hospitals Bangalore Karnataka
India Apollo Research and Innovations, Apollo Hospitals International Ltd Gandhinagar Gujarat
India Centre for Liver Research & Diagnostics, Deccan College of Medical Sciences, Owaisi Hospital & Research Centre Hyderabad Andhra Pradesh
India SR Kalla Memorial Gastro & General Hospital Jaipur Rajasthan
India King George Medical University Lucknow Uttar Pradesh
India Dayanand Medical College and Hospital Ludhiana Punjab
India Midas Multispeciality Hospital Pvt.Ltd. Nagpur Maharashtra
India Escorts Heart Institute and Research Centre Ltd New Delhi Delhi
India Poona Medical Foundation. Ruby Hall Clinic Pune Maharashtra
India Shree Giriraj Multispeciality Hospital Rajkot Gujarat
India Nirmal Hospital Pvt Ltd. Surat Gujarat
India Gandhi Hospital Telangana
India Datta Meghe Institute of Medical Sciences (DU), Acharya Vinoba Bhave Rural Hospital Wardha Maharashtra
Ireland Beaumont Hospital, Dublin Dublin
Israel Shaare Zedek Medical Center Bait Vagan Jerusalem
Israel Soroka Medical Center - Pediatric Outpatient Clinic Beer-Sheva
Israel Galilee Medical Center Department of Internal Medicine A Nahariya
Israel Kaplan Medical Center Rehovot
Israel Tel Aviv Sourasky Medical Center Tel Aviv
Israel King Fahad Medical City Zerifin
Italy Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia (Presidio Spedali Civili) Brescia
Italy Azienda ospedaliero-universitaria Mater Domini Catanzaro
Italy Azienda Ospedaliero Universitaria San Martino Genova
Italy Gastroenterology and Endoscopy Unit IRCCS Ca' Granda Ospedale Maggiore Policlinico Foundation Milano
Italy Azienda Ospedaliera Universitaria Policlinico de Modena Modena
Italy Azienda Ospedaliera Universitaria Pisana Pisa
Italy Presidio di Rho Rho Milano
Italy Policlinico Gemelli - Università Cattolica del Sacro Cuore Roma
Italy Ospedale Sandro Pertini Rome Roma
Italy Istituto Clinico Humanitas Rozzano Milano
Italy Istituti di Ricovero e Cura a Carattere Scientifico Policlinico San Donato Gastroenterologia San Donato Milanese Milano
Italy Ospedale Mauriziano Umberto I Torino
Italy Azienda Ospedaliera Universitaria Policlinico Tor Vergata Torre Roma
Italy Azienda Ospedaliero-Universitaria Santa Maria della Misericordia Gastroenterologia Udine
Japan Asahikawa City Hospital Asahikawa Hokkaido
Japan Tokyo Medical and Dental University Hospital Bunkyo Tokyo
Japan Juntendo University Hospital Bunkyo-ku Tokyo
Japan Fukuoka University Chikushi Hospital Chikushino Fukuoka
Japan Mitsui Memorial Hospital Chiyoda-ku Tokyo-To
Japan Sai Gastroenterologist Proctology Fujiidera Osaka
Japan Fukuoka University Hospital Fukuoka
Japan Matsuda Hospital Hamamatsu-shi Shizuoka-Ken
Japan National Hospital Organization Hirosaki National Hospital Hirosaki Aomori
Japan Hiroshima University Hospital Hiroshima
Japan NHO Mito Medical Center Ibaraki-machi HigaShiibaraki-Gun
Japan Sameshima Hospital Kagoshima
Japan Ofuna Central Hospital Kamakura Kanagawa
Japan Kawasaki Municipal Hospital Kawasaki Kanagawa
Japan Kitakyushu Municipal Medical Center Kitakyusyu-shi Fukoka
Japan Aoyama Clinic GI Endoscopy & IBD Center Kobe-shi Hyogo-Ken
Japan Showa University Koto Toyosu Hospital Koto-ku Tokyo
Japan Kumagaya General Hospital Kumagaya-shi Saitama-Ken
Japan Kumamoto University Hospital Kumamoto-shi Kumamoto
Japan Hidaka Coloproctology Clinic Kurume-shi Fukuoka-Ken
Japan National Hospital Organization Kyoto Medical Center Kyoto
Japan Gunma University Hospital Maebashi Gunma
Japan Kitasato University Kitasato Institute Hospital Minato-Ku Tokyo
Japan Kyorin University Hospital Mitaka Tokyo
Japan Aichi Medical University Hospital Nagakute-shi Aichi-ken
Japan Nagaoka Chuo General Hospital Nagaoka-shi Niigata
Japan Ishida Clinic of IBD and Gastroenterology Oita-shi Oita-Ken
Japan Okayama University Hospital Okayama
Japan Infusion Clinic Osaka-shi Osaka
Japan NHO Osaka National Hospital Osaka-shi Osaka
Japan Saga-Ken Medical Center Koseikan Saga-Shi Saga-Ken
Japan Tokitokai Tokito Clinic Saitama
Japan Toho University Sakura Medical Center Sakura Chiba
Japan Sapporo Higashi Tokushukai Hospital Sapporo Hokkaido
Japan Hokkaido P.W.F.A.C. Sapporo-Kosei General Hospital Sapporo-shi Hokkaido
Japan Tokushukai Sapporo Tokushukai Hospital Sapporo-shi Hokkaido
Japan Takagi Clinic - Sendai Sendai-shi Miyagi-Ken
Japan Jichi Medical University Hospital Shimotsuke-shi Tochigi-Ken
Japan Center Hospital of the National Center for Global Health and Medicine Shinjuku-ku Tokyo-To
Japan JHCO Tokyo Yamate Medical Center Shinjuku-ku Tokyo
Japan Kagawa Prefectural Central Hospital Takamatsu Kagawa
Japan National Hospital Organization Takasaki General Medical Centar Takasaki Gunma
Japan Toyama Prefectural Central Hospital Toyama
Japan Fujita Health University Toyoake Aichi
Japan Mie University Hospital Tsu Mie
Japan Showa University Northern Yokohama Hospital Yokohama Kanagawa
Japan Yokohama City University Medical Center Yokohama Kanagawa
Japan Sankikai Yokohama Shin midori General Hospital Yokohama-shi Kanagawa-Ken
Korea, Republic of Dong-A University Hospital Busan Pusan-Kwangyokshi
Korea, Republic of Inje University Haeundae Paik Hospital Busan
Korea, Republic of Yeungnam Univeristy Medical Center Daegu
Korea, Republic of The Catholic University of Korea, Daejeon St. Mary's Hospital Daejeon Taejon-Kwangyokshi
Korea, Republic of Asan Medical Center Seoul Seoul-teukbyeolsi [Seoul]
Korea, Republic of Kangbuk Samsung Hospital Seoul Seoul-teukbyeolsi [Seoul]
Korea, Republic of Kyung Hee University Hospital Seoul Korea
Korea, Republic of Samsung Medical Center Seoul Seoul-teukbyeolsi [Seoul]
Korea, Republic of Severance Hospital, Yonsei University Health System Wonju-si Gangwon-do
Latvia Digestive Diseases Center "Gastro" Riga
Latvia Pauls Stradins Clinical Univeristy Hospital Riga Riga
Latvia Riga Eastern Clinical University Hospital Riga
Lithuania Hospital of Lithuanian University of Health Sciences Kaunas Kaunas
Lithuania Klaipeda Seamen's Hospital Klaipeda
Lithuania Republic Hospital of Klaipeda Klaipeda
Lithuania Respublikine Panevezio ligonine Panevezys Panevežio Apskritis
Lithuania Vilnius University Hospital Santariskiu Clinics Vilnius
Malaysia Hospital Ampang Ampang Selangor
Malaysia Universiti Sains Malaysia Kubang Kerian Kelantan
Malaysia University Malaya Medical Centre Lembah Pantai Kuala Lumpur
Mexico Scientia Investigacion Clinica S.C. Chihuahua
Mexico Centro Para el Desarrollo de la Medicina y de Asistencia Medica S.C Culiacan Sinaloa
Mexico Centro de Investigación Clínica Acelerada Mexico City Distrito Federal
Mexico Sociedad de Metabolismo y Corazon Veracruz
Mexico Investigación Biomédica para el Desarrollo de Fármacos S.A. de C.V. Zapopan Jalisco
Netherlands Amsterdam UMC, locatie AMC Amsterdam Noord-Holland
Netherlands St Elisabeth Ziekenhuis Tilburg Noord Brabant
Netherlands Bernhoven Ziekenhuis Uden
Netherlands UMC Utrecht, Dept. of Internal Medicine, MDL Utrecht
Poland Promedica Dental Clinic Bedzin Slaskie
Poland Szpital Uniwersytecki Nr 2 im. dr J. Biziela w Bydgoszczy Bydgoszcz Kujawsko-pomorskie
Poland All-Medicus Katowice
Poland Topolowa Medicenter Krakow Malopolskie
Poland Samodzielny Publiczny Szpital Kliniczny nr 4 w Lublinie Lublin Lubelskie
Poland ZOZ Gastromed Lublin Lubelskie
Poland Medicenter Nowy Targ Nowy Targ Malopolskie
Poland Wojewodzki Specjalistyczny Szpital w Olsztynie Olsztyn
Poland KO-Med Centrum Medyczne Straszów Swietokrzyskie
Poland SONOMED Centrum Medyczne Szczecin Zachodniopomorskie
Poland Twoja Przychodnia - Szczecinskie Centrum Medyczne Szczecin
Poland Gastromed Kopon Zmudzinski I Wspólnicy Spólka Jawna Specjalistyczne Centrum Gastrologii I Endoskopii Torun
Poland NZOZ Formed Wadowice Malopolskie
Poland NZOZ Vivamed Warsaw Mazowieckie
Poland Centrum Medyczne NeuroProtect Warszawa
Poland Centrum Zdrowia MDM Warszawa
Poland Warsaw IBD Point Profesor Kierkus Warszawa
Poland LexMedica Wroclaw Dolnoslaskie
Poland PlanetMed Sp.z o.o. Wroclaw
Poland ETG Zamosc Zamosc
Romania CCBR Clinical Research Bucharest Bucure?ti
Romania Hifu Terramed Conformal SRL Bucuresti
Romania Institutul Clinic Fundeni Bucuresti
Romania MedLife Grivita Bucuresti
Romania Spitalul Clinic Colentina Bucuresti
Romania Spital Pelican Oradea Oradea
Russian Federation Multidisciplinary Medical Clinic "Anthurium" Barnaul
Russian Federation Medical and Sanitary Division of Severstal Cherepovets
Russian Federation LLC MA New Hospital Ekaterinburg
Russian Federation Scientific Centre of Reconstructive and Restorative Surgery Irkutsk Irkutskaya Oblast'
Russian Federation Alliance Biomedical URAL Group Izhevsk
Russian Federation Clinical Trials Center of Medical Institute Kaliningrad
Russian Federation State Autonomous Institution of Healthcare "Republican Clinical Hospital of the Ministry of Healthcare of Republic Tatarstan Kazan
Russian Federation SIH Kemerovo Regional Clinical Hosptial Kemerovo
Russian Federation Medical rehabilitation center Moscow
Russian Federation Nizhny Novgorod Regional Hospital N.A. Semashko Nizhny Novgorod Nizhegorodskaya Oblast'
Russian Federation Private Healthcare Institution Clinical Hospital Russian Railways - Medicine of Nizhniy Novgorod Nizhny Novgorod Nizhegorodskaya Oblast'
Russian Federation LLC "Medicine Center SibNovoMed" Novosibirsk
Russian Federation Novosibirski Gastrocenter Novosibirsk Novosibirskaya Oblast'
Russian Federation Clinical Diagnostic Center Ultramed Omsk
Russian Federation Karelia Republican Hospital V.A. Baranova Petrozavodsk Kareliya, Respublika
Russian Federation Rostov State Medical University Rostov-on-Don Rostovskaya Oblast'
Russian Federation Saint Petersburg State Medical University n.a. Pavlov I.P. Saint Petersburg
Russian Federation Scientific research center ECO-security Saint Petersburg Sankt-Peterburg
Russian Federation Non-state Healthcare Institution "Roadway Clinical Hospital of OJSC Russian Railways Saint-Petersburg
Russian Federation Pokrovskaya Municipal Hospital Saint-Petersburg
Russian Federation SBIH City Clinical Hospital #31 Saint-Petersburg
Russian Federation Medical Institute REAVIZ Samara
Russian Federation City Mariinskaya Hospital St. Petersburg
Russian Federation Stavropol State Medical University Stavropol
Russian Federation Yaroslavl Municipal HI Clinical Hospital #8 Yaroslavl
Serbia Clinical Hospital Center Zvezdara Belgrade Beograd
Serbia University Medical Center "Bezanijska kosa" Belgrade NAP
Serbia Clinical Center Kragujevac Gastroenterohepatology Clinic Kragujevac
Serbia Regional Hospital Dr Radivoj Simonovic Sombor Sombor Vojvodina
Serbia Sremska Mitrovica Health Centre Sremska Mitrovica Vojvodina
Serbia General Hospital "Djordje Joanovic" Zrenjanin Vojvodina
Slovakia Fakultna nemocnica s poliklinikou Roosevelta Banska Bystrica Banska Bystrica
Slovakia Univerzitna nemocnica Bratislava Bratislava
Slovakia KM Management Nitra Nitriansky Kraj
Slovakia Gastro Prešov Prešovský Kraj
Slovakia Endomed, s.r.o. Vranov N. Toplou Prešovský Kraj
Spain Instituto de Ciencias Médicas Alicante
Spain Hospital De Fuenlabrada Fuenlabrada Madrid
Spain Hospital Universitari de Girona Girona
Spain Hospital Universitario Juan Ramon Jimenez Huelva
Spain Complexo Hospitalario Universitario A Coruña, CHUAC La Coruña
Spain Hospital De Gran Canaria Dr. Negrin Las Palmas de Gran Canaria
Spain Hospital Universitario La Paz Madrid
Spain Hospital Universitario Central de Asturias Oviedo
Spain Hospital Universitari Son Espases Palma de Mallorca Baleares Islands
Spain Hospital Gen. Juan Ramon Jimenez - Depto de Digestivo Sagunto Valencia
Spain Hospital Universitario Marqués de Valdecilla Santander Cantabria
Spain Hospital Universitario Virgen Del Rocio Sevilla Andalucía
Switzerland Gastroenterologische Praxis Balsiger, Seibold & Partner Bern Berne
Switzerland Inselspital Bern Berne
Switzerland Kantonsspital St.Gallen St.Gallen
Switzerland UniversitätsSpital Zürich Zürich
Taiwan China Medical University Hospital Taichung
Taiwan Health management center Taipei
Turkey Ege Universitesi Hastanesi Izmir
Turkey Kocaeli University Medical Faculty Hospital Izmit Kocaeli
Turkey Acibadem Universitesi - Acibadem Kozyatagi Hastanesi Kadikoy Istanbul
Turkey Antalya Egitim ve Arastirma Hastanesi Kocaeli Antalya
Turkey Mersin University Medical Faculty Yenisehir Mersin
Ukraine Ivano-Frankivsk Regional Clinical Hospital Ivano-Frankivsk Ivano-Frankivsk Region
Ukraine City Clinical Hospital No. 2 Kharkiv Kharkivska Oblast
Ukraine GI L.T. Malaya TI Namsu Kharkiv
Ukraine Kharkiv City Student Hospital Kharkiv
Ukraine Kherson City Clinical Hospital Kherson Khersonska Oblast
Ukraine Medical Center of Limited Liability Company "Medical Center "Consilium Medical" Kiev Kyiv
Ukraine Treatment-Diagnostic Center of Private Enterprise of PPC Atsynus Kropyvnytskyi
Ukraine Communal institution of the Kyiv Regional Council "Kyiv Regional Clinical Oncology Dispensary" Kyiv
Ukraine Communal institution of the Kyiv Regional Council "Kyiv Regional Clinical Oncology Dispensary" Kyiv
Ukraine Kyiv Municipal Clinical Hospital #1 Kyiv
Ukraine Lviv Railway Clinical Hospital Lviv Lvivska Oblast
Ukraine Lviv Regional Endocrinology Dispensary Lviv Lvivska Oblast
Ukraine Municipal non-profit enterprise "Lviv Territorial Medical Union "Multidisciplinary Clinical Hospital of Em -T Lviv Lvivska Oblast
Ukraine Communal Enterprise "Odesa Regional Clinical Hospital" Odesa
Ukraine Poltova Oblast Clinical Hospital IM.M.V.Sklifosovskoho Poltava Poltavska Oblast
Ukraine A. Novak Transcarpathian Regional Clinical Hospital Uzhgorod
Ukraine CCH #1 Vinnytsia M.I. Pyrogov NMU Ch of Propaedeutics of IM Vinnytsia
Ukraine MCIC MC LLC Health Clinic Vinnytsia
Ukraine Vinnytsia RCH of Veterans of War Dept of Therapy#1 Vinnytsia M.I.Pyrogov NMU Vinnytsia
Ukraine M.I. Pyrogov Regional Clinical Hospital Vinnytsya
Ukraine Diaservis - Medical and Diagnostic Center Zaporizhia Zaporizka Oblast
Ukraine Communal Institution of Kyiv Regional Council Kyiv Regional Hospital #2 Zaporizhzhia
United Kingdom Fairfield General Hospital Bury Great Britain
United Kingdom St Thomas' Hospital Great Maze Pond London
United Kingdom St James's University Hospital Leeds Vinnytsia
United Kingdom Whipps Cross University Hospital London Surrey
United Kingdom Queens Hospital Romford Essex
United Kingdom Morriston Hospital Swansea Swansea [Abertawe Gb-ata]
United States Valley Gastroenterology Arcadia California
United States Digestive Healthcare of Georgia Atlanta Georgia
United States Texas Digestive Disease Consultants Baton Rouge Louisiana
United States Care Access Research Berkeley California
United States University of North Carolina Center for Inflammatory Bowel Disease Chapel Hill North Carolina
United States Clinical Research Institute of Michigan, LLC Chesterfield Michigan
United States Digestive Health Specialists of the Southeast Dothan Alabama
United States NorthShore University HealthSystem Evanston Illinois
United States Digestive Health Associates of Texas Garland Texas
United States Gastro One Germantown Tennessee
United States Northwell Health Great Neck New York
United States Carolina Digestive Diseases and Endoscopy Center Greenville North Carolina
United States Direct Helpers Research Center Hialeah Florida
United States Galen Medical Group Hixson Tennessee
United States Biopharma Informatic, LLC Houston Texas
United States Houston Methodist Research Ins Houston Texas
United States Grand Teton Research Group Idaho Falls Idaho
United States Indiana University School of Medicine Indianapolis Indiana
United States Nature Coast Clinical Research, LLC Inverness Florida
United States Care Access Research LLC Jackson Mississippi
United States Gen1 Research - Gastroenterology Consultants of the North Shore Kenilworth Illinois
United States SIH Research, LLC Kissimmee Florida
United States Om Research, LLC Lancaster California
United States Emeritas Research Group Leesburg Virginia
United States Dcr-Pi, Pc Litchfield Park Arizona
United States Research Associates of South Florida, LLC Miami Florida
United States Wellness Clinical Research Miami Lakes Florida
United States Paramount Medical Research Middleburg Heights Ohio
United States Wisconsin Center for Advanced Research Milwaukee Wisconsin
United States Gen1 - Digestive Disease Specialist Moline Illinois
United States Delta Research Partners LLC Monroe Louisiana
United States Nola Research Works, LLC New Orleans Louisiana
United States Weill Cornell Medical College New York New York
United States Central Sooner Research Norman Oklahoma
United States California Medical Research Associates Northridge California
United States Henry Ford Health System Novi Michigan
United States Care Access Research LLC - Salt Lake City Ogden Utah
United States University of Oklahoma Health Sciences Center Oklahoma City Oklahoma
United States Center for Interventional Endoscopy Orlando Florida
United States Clintheory Healthcare Orlando Florida
United States Gastroenterology Associates of Pensacola, PA Pensacola Florida
United States Maricopa Integrated Health System Phoenix Arizona
United States MNGI Digestive Health - Plymouth Endoscopy Center & Clinic Plymouth Minnesota
United States Care Access - Youngstown Poland Ohio
United States The Gastroenterology Group, P.C. Reston Virginia
United States Carilion Clinic Roanoke Virginia
United States Gastroenterology Research of San Antonio San Antonio Texas
United States Southern Star Research Institute, LLC San Antonio Texas
United States Clinical Applications Laboratories, Inc. San Diego California
United States UCSF Medical Center at Mission Bay San Francisco California
United States Midwest Medical Care Sioux Falls South Dakota
United States Texas Digestive Disease Consultants Southlake Texas
United States Physicians Research Group Tempe Arizona
United States Cotton-O'Neil Clinical Research Center, Digestive Health Topeka Kansas
United States Digestive Health Specialists Tupelo Mississippi
United States Gastroenterology Associates of Western Michigan, P.L.C. Wyoming Michigan
United States Digestive Disease Associates Wyomissing Pennsylvania
United States Huron Gastroenterology Associates Ypsilanti Michigan
United States Florida Medical Clinic LLC Zephyrhills Florida

Sponsors (1)

Lead Sponsor Collaborator
Eli Lilly and Company

Countries where clinical trial is conducted

United States,  Argentina,  Australia,  Austria,  Belgium,  Canada,  China,  Czechia,  Denmark,  France,  Germany,  Hungary,  India,  Ireland,  Israel,  Italy,  Japan,  Korea, Republic of,  Latvia,  Lithuania,  Malaysia,  Mexico,  Netherlands,  Poland,  Romania,  Russian Federation,  Serbia,  Slovakia,  Spain,  Switzerland,  Taiwan,  Turkey,  Ukraine,  United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Primary Percentage of Participants in Clinical Remission at Week 40 Clinical remission at week 40 is defined as achieving a 9-point modified Mayo score for rectal bleeding=0, stool frequency=0 or 1 with = 1 point decrease from baseline, and endoscopy=0 or 1 (excluding friability).
Stool Frequency Subscore, based on the participant's diary and scored from 0 (normal number of stools) to 3 (5 or more stools than normal); Rectal Bleeding Subscore, based on the participant's diary and scored from 0 (no blood) to 3 (blood only passed); Endoscopy Subscore, based on central reading of colonoscopy or sigmoidoscopy and scored from 0 (normal or inactive disease) to 3 (severe disease, spontaneous bleeding, ulceration).
Week 40
Secondary Percentage of Participants in Endoscopic Remission at Week 40 Endoscopic remission at week 40 is defined as achieving a Mayo endoscopic subscore of 0 or 1 (excluding friability) at Week 40. Endoscopy subscore is based on colonoscopy or sigmoidoscopy and scored from 0 (normal or inactive disease) to 3 (severe disease, spontaneous bleeding, ulceration). Week 40
Secondary Percentage of Participants With Histologic Remission at Week 40 Histologic remission was assessed using the Geboes histologic scoring system developed for assessment of histologic disease activity in ulcerative colitis. Remission was defined as Geboes histological subscore of 0 for grades: 2b (lamina propria neutrophils), and 3 (neutrophils in epithelium), and 4 (crypt destruction), and 5 (erosion or ulceration). Week 40
Secondary Percentage of Participants in Symptomatic Remission at Week 40 Symptomatic remission at week 40 is defined as a Mayo score for rectal bleeding=0, stool frequency=0 or 1 with = 1 point decrease from baseline.
Stool frequency subscore, based on the participant's diary and scored from 0 (normal number of stools) to 3 (5 or more stools than normal).
Rectal bleeding subscore, based on the participant's diary and scored from 0 (no blood seen) to 3 (blood alone passed).
Week 40
Secondary Percentage of Participants in Endoscopic Response at Week 40 Endoscopic response at week 40 is defined as achieving at least a 1 point decrease from baseline in the Mayo endoscopic subscore. Week 40
Secondary Percentage of Participants in Clinical Response at Week 40 Clinical response at week 40 is defined as a decrease in the 9-point modified Mayo score (MMS) [rectal bleeding, stool frequency and the endoscopic findings] inclusive of >= 2 points and >=30% from baseline with either a decrease of rectal bleeding subscore of >=1 or rectal bleeding subscore of 0 or 1.The MMS is a composite score of ulcerative colitis disease activity calculated as the sum of three subscores: Stool frequency subscore, based on the participant's diary and scored from 0 (normal number of stools) to 3 (5 or more stools than normal); Rectal bleeding subscore, based on the participant's diary and scored from 0 (no blood seen) to 3 (blood alone passed); Endoscopy subscore, based on colonoscopy or sigmoidoscopy and scored from 0 (normal or inactive disease) to 3 (severe disease, spontaneous bleeding,ulceration). Week 40
Secondary Change From Baseline to Week 40 in Health Related Quality of Life: Inflammatory Bowel Disease Questionnaire (IBDQ) Total Score The IBDQ is a 32-item participant-completed questionnaire that measures 4 aspects of subjects' lives: symptoms directly related to the primary bowel disturbance, systemic symptoms, emotional function, and social function. Responses are graded on a 7-point. Likert scale in which 7 denotes "not a problem at all" and 1 denotes "a very severe problem." Scores range from 32 to 224; a higher score indicates a better quality of life. Least square (LS) Mean was calculated using analysis of covariance (ANCOVA) model for post-baseline measures: The ANCOVA model includes: treatment, baseline value, prior biologic or tofacitinib failure (yes/no), clinical remission status (yes/no) at AMAN Week 12, and region (North America/Europe/Other). Induction Baseline, Week 40
Secondary Change From Baseline to Week 40 in Fecal Calprotectin Fecal calprotectin is an indicator of inflammation in the colon with higher levels indicative of higher levels of inflammation. Least square (LS) Mean was calculated using ANCOVA model for post-baseline measures: The ANCOVA model includes treatment, baseline value, prior biologic or tofacitinib failure (yes/no), corticosteroid use (yes/no) at AMAN baseline, region (North America/Europe/Other), Clinical Remission status (yes/no) at AMAN Week 12. Induction Baseline, Week 40
Secondary Change From Baseline to Week 40 in Bowel Urgency Based on the Urgency Numeric Rating Scale (NRS) The Urgency NRS is a single participant reported item that measures the severity for the urgency (sudden or immediate need) to have a bowel movement in the past 24 hours using an 11-point NRS ranging from 0 (no urgency) to 10 (worst possible urgency). Higher scores indicate more severe urgency. Least square (LS) Mean was calculated using mixed model repeated measures (MMRM) model for post-baseline measures: The MMRM model includes treatment, baseline value, visit, interaction of baseline value-by-visit, interaction of treatment-by-visit, prior biologic or tofacitinib failure (yes/no), baseline corticosteroid use (yes/no), clinical remission status (yes/no) at AMAN Week 12, and region (North America/Europe/Other). Induction Baseline, Week 40
Secondary Percentage of Participants Hospitalized for Ulcerative Colitis (UC) Percentage of participants hospitalized for UC. Only hospitalizations associated with an adverse event with >=24 hours stay were recorded. Week 40
Secondary Pharmacokinetics (PK): Clearance of Mirikizumab Clearance of mirikizumab was evaluated. Predose: Weeks 0, 4, 12, 24 and 40
See also
  Status Clinical Trial Phase
Recruiting NCT05702879 - Combined Microbiota and Metabolic Signature in Ulcerative Colitis Predicts Anti-Inflammatory Therapy Success
Not yet recruiting NCT05953402 - A Study of Ozanimod in Pregnant Women With Ulcerative Colitis and Their Offspring
Recruiting NCT05316584 - A Novel Remote Patient and Medication Monitoring Solution to Improve Adherence and PerSiStence With IBD Therapy N/A
Recruiting NCT03950232 - An Extension Study for Treatment of Moderately to Severely Active Ulcerative Colitis Phase 3
Completed NCT03124121 - Study of the Golimumab Exposure-Response Relationship Using Serum Trough Levels Phase 4
Not yet recruiting NCT06100289 - A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease Phase 3
Withdrawn NCT04209556 - A Study To Evaluate The Safety And Efficacy Of PF-06826647 In Participants With Moderate To Severe Ulcerative Colitis Phase 2
Terminated NCT00061282 - Clotrimazole Enemas for Pouchitis in Children and Adults Phase 1/Phase 2
Recruiting NCT04398550 - SCD vs. Mediterranean Diet Therapy in Ulcerative Colitis N/A
Recruiting NCT04314375 - Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Budesonide Extended-release Tablets in Pediatric Subjects Aged 5 to 17 Years With Active, Mild to Moderate Ulcerative Colitis Phase 4
Active, not recruiting NCT04857112 - Study Evaluating Efficacy and Safety of Amiselimod (MT-1303) in Mild to Moderate Ulcerative Colitis Phase 2
Completed NCT05051943 - A Study of the Real-world Use of an Adalimumab Biosimilar and Evaluation of Nutritional Status on the Therapeutic Response
Active, not recruiting NCT04033445 - A Study of Guselkumab in Participants With Moderately to Severely Active Ulcerative Colitis Phase 2/Phase 3
Recruiting NCT05428345 - A Study of Vedolizumab SC Given to Adults With Moderate to Severe Ulcerative Colitis or Crohn's Disease in South Korea
Active, not recruiting NCT06221995 - Energy Expenditure in Patients With Ulcerative Colitis Undergoing Surgery
Recruiting NCT04767984 - Testing Atorvastatin to Lower Colon Cancer Risk in Longstanding Ulcerative Colitis Phase 2
Completed NCT02508012 - Medico-economic Evaluation of the Therapeutic Drug Monitoring of Anti-TNF-α Agents in Inflammatory Bowel Diseases N/A
Recruiting NCT06071312 - FMT in Patients With Recurrent CDI and Ulcerative Colitis: Single Infusion Versus Sequential Approach Phase 1/Phase 2
Completed NCT03760003 - Dose-Ranging Phase 2b Study of ABX464 in Moderate to Severe Ulcerative Colitis Phase 2
Not yet recruiting NCT05539625 - Mini-MARVEL - Mitochondrial Antioxidant Therapy in Ulcerative Colitis Phase 2